Corteva is expected to see significant stock growth as it emphasizes its agricultural chemical operations, according to JPMorgan's recent analysis. The investment bank raised its rating on Corteva from neutral to overweight, setting a price target of $19, which suggests a potential upside of 53% from the stock's closing price on Monday.
This strategic shift follows Corteva's recent spinout of its seed business into a new entity called Vylor, allowing the company to concentrate on in-licensing new crop chemical molecules that are anticipated to have strong growth prospects and higher profit margins.
Analyst Jeffrey Zekauskas noted that despite some ongoing legal challenges, including a lawsuit related to the use of certain chemicals, the overall market conditions for agricultural commodities are improving. He highlighted that corn prices have recently stabilized around $5 per bushel, which could lead to more favorable pricing trends in the crop chemical sector.
Currently, 15 out of 23 analysts covering Corteva have rated the stock as a buy or strong buy, indicating a generally positive outlook despite a recent 6% decline in shares over the past month, which has been attributed to the spinout and legal issues. However, Corteva's stock remains up 23% year to date, reflecting investor confidence in its long-term growth potential